The United States Insulin Pump Market is projected to grow from US$ 1.55 billion in 2024 to US$ 2.58 billion in 2033, with a ...

Manufacturing line has now been validated for human-use production in support of expected Q1 2026 market launch. Pivot will be First Two-Part Tubeless Patch Pump: Pivot, a 3 milliliter removable patch ...

In a letter to CMS Administrator Mehmet Oz, diabetes caucus leaders raised concerns that the agency’s proposals will reduce ...

Manufacturing line has now been validated for human-use production in support of expected Q1 2026 market launch.Pivot will be First Two-Part Tubeless Patch ...

Because Congress hasn’t extended pandemic-era subsidies that made ACA plans inexpensive, health insurance cost will spike for ...

An Institute for Clinical and Economic Review report concluded that the GLP-1 drugs tirzepatide and semaglutide (Ozempic, ...

RBC Capital is particularly bullish on Insulet. Investor sentiment is positive ahead of the company’s Q3 earnings report ...

In their letter to Administrator Oz, the lawmakers highlighted that including CGMs and insulin pumps in the Medicare competitive bidding program would limit the number of device suppliers, which would ...

Kerrie Matthews has been forced to sell personal items to afford life-saving diabetes equipment, and with skyrocketing bills ...

The Global Diabetes Devices Market is projected to expand at a compound annual growth rate (CAGR) of approximately 6% by 2026. Key drivers of this growth include the rising incidence of diabetes, ...

Type 2 diabetes (T2D) is a chronic metabolic disorder characterised by insulin resistance and impaired insulin secretion, ...

Image from Modular Medical on LinkedIn]Modular Medical (Nasdaq:MODD) announced that it continues to progress toward CE mark ...